News

Rigel’s R256 inhaled JAK inhibitor, which was shown to inhibit IL-13 and IL-4 signaling, is being investigated as a treatment for moderate to severe chronic asthma. R256 demonstrated

Upon completion of the merger, approved by Ardea’s stockholders, each outstanding share of Ardea common stock has been cancelled and converted into the right to receive $32.00, in

The product is offered in a five-pack or a 24-pack and can be purchased by visiting the Nouveau Life online store. Nouveau Life CEO Melissa Walker said Azul

Daiichi Sankyo Venezuela, which has already started the promotion, would begin marketing Ranbaxy products. Ranbaxy has been marketing its drugs in Venezuela through a local distributor. With the

Under the agreement, Lipotec will take over cosmetic active ingredients business and its subsidiaries, Diverdrugs and Lipofoods. The transaction, which is expected to close within 60 days and

XD technology is a cell culture process with achievement of 5-to-15 times higher in comparison to current standard bio manufacturing processes. It is widely applicable for multiple products

The MHRA inspected CMC Biologics’ manufacturing and testing facilities in Bothell, WA in late March 2012. CMC Biologics chief operations officer Gustavo Mahler said, "This achievement demonstrates the

The FDA’s Center for Biologics Evaluation and Research conducted a pre-approval inspection of Cook Pharmica in February 2012, which covered the company’s new vial filling line, lyophilization capabilities

Duexis is a proprietary single-tablet combination of the NSAID ibuprofen and the histamine H2-receptor antagonist famotidine. The product is indicated for the relief of signs and symptoms of